A

00241

Alibaba Health Information Techn…

4.98

-0.11-2.16%
Closed16:08 05/09 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE5.130/5.090
TODAY RANGE4.920-5.130
VOL48.91M
MARKET CAP80.14B
52 WEEK RANGE2.660-6.700
AVG VOL (3M)214.38M
% TURNOVER0.30%
TURNOVER244.42M
P/E (TTM)59.900
% RANGE4.13%
EPS(TTM)0.083
P/E(FORWARD)43.608
P/B4.731
BVPS1.053
DIVIDEND--
P/S2.148
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP80.14B
SHARES OUTSTANDING16.09B
NEXT EARNINGS--
FREE FLOAT16.09B
LOT SIZE2000
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

S

Sinopharm Group

01099

+0.55%
18.400

C

Charmacy Pharmaceutical

02289

0.00%
7.750

K

Kingworld Medicines Group

01110

+3.85%
0.540

S

Shanghai Pharmaceuticals Holding

02607

-1.10%
10.800

N

New Ray Medicine International Holding

06108

+2.38%
0.043

S

Shanghai Pioneer Holding

01345

0.00%
2.260

Z

Zhongzhi Pharmaceutical Holdings

03737

0.00%
0.950

Q

Qianhai Health Holdings

00911

0.00%
0.205

C

China NT Pharma Group

01011

-6.85%
0.340

S

Sinco Pharmaceuticals Holdings

06833

-0.55%
0.182

D

Dingdang Health Technology Group

09886

+1.39%
0.365

S

Sipai Health Technology

00314

+0.94%
4.280

W

Wanjia Group Holdings

00401

+2.94%
0.070

M

Meilleure Health International Industry Group

02327

+3.33%
0.310

T

Tycoon Group Holdings

03390

-2.20%
0.445

U

Universal Health International Group Holding

02211

0.00%
0.077

P

Pa Shun International Holdings

00574

0.00%
0.030

Q

Qianhai Health Holdings

02978

--
0.010

J

JD Health International

06618

-3.15%
36.850

W

Wanjia Group Holdings

02970

--
0.010
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.